TIPRL and hepatocellular carcinoma: Among the four variables, TIPRL (HR 3.4 95%CI = 1.1–11.1, p = 0.04) exhibits significant prognostic influence on HCC patients but LC3 (HR 0.2 95%CI = 0.1–1.1, p = 0.05), CD133 (HR 1.1 95%CI = 0.5–2.7, p = 0.45) and sex (HR 0.2 95%CI = 0.0–0.5, p < 0.0001) do not.